Weinberg Jonathan 4
4 · Evolent Health, Inc. · Filed Jul 6, 2026
Research Summary
AI-generated summary of this filing
Evolent Health (EVH) GC Jonathan Weinberg Receives 43,055 RSUs
What Happened
Jonathan Weinberg, General Counsel of Evolent Health (EVH), was granted 43,055 restricted stock units (RSUs) on July 1, 2026 (reported as an award, code A). On the same date, 2,650 shares were withheld to satisfy tax withholding (code F) at $5.74 per share, totaling $15,211. The RSU grant is compensation — not an open‑market purchase or sale.
Key Details
- Transaction dates: July 1, 2026 (award and tax withholding); Form 4 filed July 6, 2026. The filing appears late relative to the usual two-business-day Form 4 deadline.
- Award: 43,055 RSUs granted (price reported $0.00 as typical for RSUs).
- Tax withholding: 2,650 shares withheld at $5.74/share = $15,211 (reported as a disposition under code F).
- Vesting: 34% on July 1, 2027; 33% on July 1, 2028; 33% on July 1, 2029 (per filing).
- Plan and approvals: This tranche was part of the annual award cycle; a first portion was granted March 2, 2026, and shareholders approved additional shares for the omnibus plan on June 4, 2026. The award includes RSUs from previously reported awards.
- Shares owned after the transaction: Not provided in the excerpt of the filing.
- Transaction codes explained: A = award/grant; F = shares withheld to satisfy tax withholding upon vesting (cashless-type withholding).
Context
RSU grants are a form of compensation intended to align executives with shareholder interests over time; they vest in future years rather than representing an immediate market purchase. The small number of shares withheld for taxes reduces the net increase in holdings and is routine. This filing reports a compensation grant rather than a directional insider trade.
Insider Transaction Report
- Award
Class A Common Stock
[F1][F2][F3][F4]2026-07-01+43,055→ 287,567 total - Tax Payment
Class A Common Stock
[F5][F4]2026-07-01$5.74/sh−2,650$15,211→ 284,917 total
Footnotes (5)
- [F1]Represents restricted stock units granted to Mr. Weinberg pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
- [F2]Represents a portion of the award approved by the Compensation Committee of the Company's Board of Directors as part of the annual award cycle. The first portion of the award was granted on March 2, 2026, and this portion of the award was granted on July 1, 2026, following the issuance of additional shares under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. The Company's shareholders approved the issuance of additional shares under the Amended and Restated 2015 Omnibus Incentive Compensation Plan on June 4, 2026, at the Company's Annual Meeting.
- [F3]Securities vest at a rate of 34% on July 1, 2027, and 33% on July 1, 2028, and July 1, 2029.
- [F4]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F5]This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.